About
Sara Garcia-Ratés is Chief Scientific Officer at Neuro-Bio Ltd, a UK biotechnology company developing diagnostics and therapeutics related to Alzheimer’s disease and other neurodegenerative pathways. She holds a PhD in Neuropharmacology and Drug Development from the University of Barcelona and previously worked with Susan Greenfield at Oxford University as a postdoctoral researcher. Public sources describe her progression at Neuro-Bio from bench scientist through therapeutics and operations roles to CSO, with responsibility for biomarker, therapeutics, and patent-portfolio development.
Areas of interest
Alzheimer's diseaseneurodegenerationneuropharmacologydrug developmentbiomarkersagingskin agingbiotechpatent strategy